A Phase 1b Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of Oprozomib in Combination with Pomalidomide and Dexamethasone in Subjects with Relapsed or Refractory Multiple Myeloma

Project: Research

Project Details

Project Description

NMA HREC Reference Number: HREC/17/MonH/390
NMA SSA Reference Number: SSA/17/MonH/428
Monash Health Ref: 17-0000-478A
Effective start/end date7/05/196/05/24


  • clinical trial
  • Myeloma
  • treatment efficacy